Collagen Powder in Wound Healing

J Drugs Dermatol. 2018 Apr 1;17(4):403-408.


Chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, are associated with high costs, poor quality of life, and significant morbidity and mortality. A chronic wound develops when progression through the normal phases of wound healing goes awry, creating a hostile environment with elevated levels of pro-inflammatory cytokines, increased matrix metalloproteinases (MMPs), destruction of extracellular matrix (ECM) components, and diminished activity of growth factors and other soluble mediators. The advent of advanced wound care therapies allows for a targeted approach to the treatment of nonhealing wounds by addressing specific molecular defects in healing. Collagen is an essential building block of the skin that when utilized as an adjunctive wound therapy stimulates and recruits immune cells and fibroblasts and martyrs itself for degradation by MMPs, thereby preserving native ECM structure and promoting healing. Particulate or powdered collagen is processed to minimize covalent cross-linking and is purported to exert its biologic activity immediately upon application. This article critically reviews the current evidence for collagen powder as an adjunctive therapy for chronic wounds and presents indications, limitations, and principles of use. In general, there is a need for high quality studies and randomized control trials to support its use in clinical practice. <p><em>J Drugs Dermatol. 2018;17(4):403-408.</em></p>.

Publication types

  • Review

MeSH terms

  • Animals
  • Bandages*
  • Collagen / administration & dosage*
  • Humans
  • Matrix Metalloproteinases / administration & dosage
  • Powders
  • Wound Healing / drug effects*
  • Wound Healing / physiology*


  • Powders
  • Collagen
  • Matrix Metalloproteinases